APA

Ross D. M., Watkins D. B., Hughes T. P. & Branford S. (20080912). Reverse transcription with random pentadecamer primers improves the detection limit of a quantitative PCR assay for BCR-ABL transcripts in chronic myeloid leukemia: implications for defining sensitivity in minimal residual disease. : Clinical chemistry.

Chicago

Ross David M, Watkins Dale B, Hughes Timothy P and Branford Susan. 20080912. Reverse transcription with random pentadecamer primers improves the detection limit of a quantitative PCR assay for BCR-ABL transcripts in chronic myeloid leukemia: implications for defining sensitivity in minimal residual disease. : Clinical chemistry.

Harvard

Ross D. M., Watkins D. B., Hughes T. P. and Branford S. (20080912). Reverse transcription with random pentadecamer primers improves the detection limit of a quantitative PCR assay for BCR-ABL transcripts in chronic myeloid leukemia: implications for defining sensitivity in minimal residual disease. : Clinical chemistry.

MLA

Ross David M, Watkins Dale B, Hughes Timothy P and Branford Susan. Reverse transcription with random pentadecamer primers improves the detection limit of a quantitative PCR assay for BCR-ABL transcripts in chronic myeloid leukemia: implications for defining sensitivity in minimal residual disease. : Clinical chemistry. 20080912.